Regardless, data on the biology and function of IL-23 in IBD argue for the overall colitogenic rather than inflammation-reducing nature of Th17 cells given the fact that IL-23 has been revealed to be one, if not the most important cytokine acting upstream of Th17 cells providing crucial signals for their survival and proliferation (10–13). This evidence concerns the gene IL23A and inflammatory bowel disease.